OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 61 filers reported holding OVID THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,776 | +10.8% | 22,077 | -5.4% | 0.00% | – |
| Q2 2023 | $76,513 | +21.9% | 23,327 | -4.1% | 0.00% | – |
| Q1 2023 | $62,766 | +38.7% | 24,328 | 0.0% | 0.00% | – |
| Q4 2022 | $45,250 | -20.6% | 24,328 | -22.1% | 0.00% | – |
| Q3 2022 | $57,000 | -14.9% | 31,228 | 0.0% | 0.00% | – |
| Q2 2022 | $67,000 | -63.4% | 31,228 | -46.5% | 0.00% | -100.0% |
| Q1 2022 | $183,000 | -37.3% | 58,365 | -35.8% | 0.00% | 0.0% |
| Q4 2021 | $292,000 | -10.4% | 90,852 | -6.3% | 0.00% | 0.0% |
| Q3 2021 | $326,000 | -28.7% | 96,998 | -16.9% | 0.00% | -50.0% |
| Q2 2021 | $457,000 | -27.3% | 116,760 | -25.4% | 0.00% | 0.0% |
| Q1 2021 | $629,000 | +97.8% | 156,482 | +13.7% | 0.00% | +100.0% |
| Q4 2020 | $318,000 | -66.4% | 137,660 | -16.4% | 0.00% | -75.0% |
| Q3 2020 | $946,000 | +65.4% | 164,736 | +112.4% | 0.00% | +33.3% |
| Q2 2020 | $572,000 | +194.8% | 77,556 | +19.3% | 0.00% | +200.0% |
| Q1 2020 | $194,000 | -75.4% | 65,000 | -65.8% | 0.00% | -75.0% |
| Q4 2019 | $790,000 | – | 190,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |